BUY Divi's Laboratories Limited — Rakesh Bansal
byRakesh BansalHorizon: Swing (≤2wk)3 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Divi's Labs Q1 Results: Profit Jumps 65.5%, Revenue Up 28% - Key Numbers
NewsNdtv-Profit·1 Aug · yesterday
Divi’s Laboratories Q1 profit surges 66% to ₹902 crore, revenue rises 28%
NewsCnbc-Tv18·1 Aug · yesterday
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·29 Jul · 5d ago
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%
NewsGoogle News·27 Jul · 6d ago
Divi's Laboratories begins commercial operations at Unit III greenfield project in Kakinada
NewsGoogle News·25 Jul · 1w ago
Q1 results today: Divi's Labs, Muthoot Finance, APL Apollo among over 30 companies set to announce Q1 earnings
NewsLivemint·1 Aug · yesterday
Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·1 Aug · yesterday
Divis Labs Ex-Dividend Date July 24: What Investors Should Know
NewsGoogle News·23 Jul · 1w ago
Divis Labs Share Price: રોકાણકારો માટે મહત્વના સમાચાર! ₹30 ડિવિડન્ડ માટે Ex-Dividend Date જાહેર
NewsGoogle News·23 Jul · 1w ago
Divis Labs: ₹30 டிவிடெண்ட்! இந்த தேதியை தவறவிடாதீர்கள்!
NewsGoogle News·23 Jul · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Ashish Bahety, Profitmart Securities22 Oct 2026 · Same day · target ₹9,350 · SL hit
- SELL — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹8,750 · SL hit
- SELL — Mehul Kothari, Anand Rathi14 Oct 2026 · ~2 weeks · target ₹8,400 · Active
- BUY — Kavita Jain, Arihant Capital Markets6 Oct 2026 · Next day · target ₹9,750 · Expired
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
More from Rakesh Bansal
- BUY Tata Elxsi22 Oct 2026 · ~2 weeks · target ₹4,006 · Active
- BUY Infosys22 Oct 2026 · ~2 weeks · target ₹1,200 · SL hit
- BUY Tata Elxsi22 Oct 2026 · ~2 weeks · target ₹4,000 · Active
- BUY Saregama India22 Oct 2026 · Same day · target ₹528 · Expired
- BUY HCL Technologies22 Oct 2026 · ~2 weeks · target ₹1,520 · Active

